The Evolving Paradigm of Antibody–Drug Conjugates Targeting the ErbB/HER Family of Receptor Tyrosine Kinases

Current therapies targeting the human epidermal growth factor receptor (HER) family, including monoclonal antibodies (mAbs) and tyrosine kinase inhibitors (TKIs), are limited by drug resistance and systemic toxicities. Antibody–drug conjugates (ADCs) are one of the most rapidly expanding classes of...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Peyton High, Cara Guernsey, Shraddha Subramanian, Joan Jacob, Kendra S. Carmon
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	MDPI AG 2024-07-01
Цуврал:	Pharmaceutics
Нөхцлүүд:	antibody–drug conjugates EGFR HER2 HER3 bispecific antibodies combination therapy
Онлайн хандалт:	https://www.mdpi.com/1999-4923/16/7/890
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!